Carl Icahn, the shareholder activist who waged two proxy fights for board seats at Forest Laboratories, Inc. (NYSE:FRX), stands to earn almost $1.7 billion in gross profits on his 11 percent stake in the drug company. Icahn paid a total of about $1.06 billion for his holdings in Forest, consisting of 30.66 million common shares, according to regulatory filings. That works out to about $34.66 a share. Forest Laboratories, Inc. (NYSE:FRX) stock opened at $92.80 in last trading session, and closed at $91.04, trading in the range of $90.21 – $93.50. The stock showed a positive weekly performance of 31.67%.
Stock analysts at HC Wainwright began coverage on shares of Prana Biotechnology (NASDAQ:PRAN) in a report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $20.50 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 182.76% from the stock’s previous close. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares closed at $10.10 on last trade day, by gaining 39.31%. Stock 52 week range is $2.09 – $13.29. Company’s market capitalization is $411.48 million.
Endo Health Solutions Inc (NASDAQ:ENDP) announced that the South African Competition Commission has completed its review and approved the merger of Endo and Paladin Labs without conditions in terms of section 14(1)(b) of the Competition Act (South Africa). In addition, the company announced that it has received regulatory approval under the Investment Canada Act. The Minister of Industry has completed a review of the transaction and determined that it is likely to produce a “net benefit” to Canada. Endo Health Solutions Inc (NASDAQ:ENDP) stock advanced 5.83% and finished the last session at $75.82. The EPS of the stock remained -5.58. Company’s market capitalization is $8.71 billion.
Zacks reiterated their neutral rating on shares of Questcor Pharmaceuticals (NASDAQ:QCOR) in a research report released on Friday morning, Analyst RN reports. Zacks currently has a $68.00 price objective on the stock. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stock opened at $70.37 in last trading session and closed at $75.83. The 52 week range of the stock is $26.80 – $76.46 and the day range was $69.73 – $76.46.